Latest Oncology Stories

SUNNYVALE, Calif., June 19, 2013 /PRNewswire/ -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC) today announced that The New England Journal of Medicine (NEJM) published results online of a Phase 1b/2 study evaluating the investigational oral Bruton's tyrosine kinase (BTK) inhibitor ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Ibrutinib was shown to be safe and effective in patients with relapsed/refractory...

A second study in relapsed/refractory mantle cell lymphoma (MCL) also published in the online edition RARITAN, N.J., June 19, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced The New England Journal of Medicine (NEJM) has published data online about the investigational oral Bruton's Tyrosine Kinase (BTK) inhibitor ibrutinib as a monotherapy in patients with chronic lymphocytic leukemia (CLL). Results from a Phase 1b/2 study show that...

A second study in relapsed/refractory chronic lymphocytic leukemia (CLL) also published in the online edition RARITAN, N.J., June 19, 2013 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced that a study published online in The New England Journal of Medicine (NEJM) demonstrates treatment with ibrutinib, an investigational oral Bruton's tyrosine kinase (BTK) inhibitor, resulted in an overall response rate of 68%, with 47% of patients achieving a partial...

Yale Cancer Center's Director of Cancer Genetic Counseling, Ellen Matloff, in NYC Tomorrow PLAINSBORO, N.J., June 19, 2013 /PRNewswire/ -- On Thursday, June 13, 2013, the Supreme Court unanimously ruled that human genes isolated from the body can't be patented. The decision, penned by Justice Clarence Thomas, was a victory for doctors, patients and geneticists who argued that such patents curtail research and limit the practice of medicine. (Photo:...

Commercial Launch of MyCare(TM) Chemotherapy Exposure Optimization Tests Initiated Through Saladax Biomedical Laboratories BETHLEHEM, Pa., June 19, 2013 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing novel diagnostic tests that help physicians to optimize a patient's exposure to chemotherapy, today announced the U.S. launch of the MyCare(TM) portfolio of exposure optimization tests. The MyCare portfolio is comprised of simple blood tests that provide...

Support 1,000 Cooks for the Cure, July 19-28 BENTON HARBOR, Mich., June 19, 2013 /PRNewswire/ -- This July, Susan G. Komen(®) and the Canadian Breast Cancer Foundation (CBCF) are partnering with KitchenAid to encourage anyone who enjoys cooking and entertaining to turn a summer gathering into a "party with a purpose" by hosting a Cook for the Cure party. The goal of this 1,000 Cooks for the Cure initiative is to enlist at least 1,000 cooks in the U.S. and Canada to host any type of...

-TNT Fuels 300 New Research Programs to Discover Breakthrough Treatments& Cures- WHITE PLAINS, N.Y., June 19, 2013 /PRNewswire/ -- This year alone, The Leukemia & Lymphoma Society (LLS) is supporting more than 300 research projects with one goal in mind: Discovering lifesaving therapies for blood cancer patients. And in 2013, "Team In Training" (TNT), a flagship LLS fundraising campaign and the world's first and largest endurance sports training program, is marking its landmark...

Colleen’s Dream Foundation has made a $10,000 gift to the University of Arizona Cancer Center in an effort to support early ovarian cancer detection research, according to Colleen’s Dream Foundation President Billy Cundiff. Phoenix, AZ (PRWEB) June 18, 2013 In an ongoing effort to support research for early detection of ovarian cancer, Colleen’s Dream Foundation has made a $10,000 gift to The University of Arizona Cancer Center, according to Colleen’s Dream Foundation President...

Global Drought and UV Radiation Makes Sunscreen Critical to Skin Cancer Prevention Reports Sharon Kleyne. Grants Pass, OR (PRWEB) June 18, 2013 New research is revealing that no matter what the weather or season, exposing skin to daylight without sunscreen is never a good idea. According to water and skin researcher Sharon Kleyne, in this era of increasing global drought, solar radiation and thinning ozone, sunscreen is becoming as important to personal health and grooming as toothpaste,...

Cancer Patient Uses Personal Tragedy to Raise Awareness, Inspire Others. Dallas, TX (PRWEB) June 18, 2013 Baron and Budd mesothelioma attorneys are saluting Janelle Bedel, a young mesothelioma patient whose courage has mustered far-reaching influence. “Janelle’s battle against mesothelioma is an inspiration,” said the mesothelioma lawyers at Baron and Budd. “Her global impact on mesothelioma awareness shows how one person can make a difference.” According to the Asbestos...